| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Newron Pharmaceuticals S.p.A (SW: NWRN)
NWRN Technical Analysis
5
| As on 14th Jan 2026 NWRN STOCK Price closed @ 26.75 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.84 & Strong Buy for SHORT-TERM with Stoploss of 8.96 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NWRNSTOCK Price
| Open | 27.50 | Change | Price | % |
| High | 27.50 | 1 Day | -1.10 | -3.95 |
| Low | 24.90 | 1 Week | 1.25 | 4.90 |
| Close | 26.75 | 1 Month | 9.59 | 55.89 |
| Volume | 446742 | 1 Year | 19.15 | 251.97 |
| 52 Week High 30.40 | 52 Week Low 6.03 | ||||
SW Switzerland Most Active Stocks
| CSGN | 0.82 | 0.00% |
| CSGN | 0.82 | 0.00% |
| UBSG | 37.75 | -0.53% |
| UBSG | 37.75 | -0.53% |
| NESN | 76.55 | 1.80% |
| NESN | 76.55 | 1.80% |
| NOVN | 115.60 | 1.72% |
| NOVN | 115.60 | 1.72% |
| MBTN | 0.00 | -100.00% |
| ABBN | 60.20 | -1.12% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
| NWRN Daily Charts |
NWRN Intraday Charts |
Whats New @ Bazaartrend |
NWRN Free Analysis |
|
|
NWRN Important Levels Intraday
| RESISTANCE | 31.76 |
| RESISTANCE | 30.15 |
| RESISTANCE | 29.16 |
| RESISTANCE | 28.17 |
| SUPPORT | 25.33 |
| SUPPORT | 24.34 |
| SUPPORT | 23.35 |
| SUPPORT | 21.74 |
NWRN Forecast January 2026
| 4th UP Forecast | 31.36 |
| 3rd UP Forecast | 29.88 |
| 2nd UP Forecast | 28.97 |
| 1st UP Forecast | 28.05 |
| 1st DOWN Forecast | 25.45 |
| 2nd DOWN Forecast | 24.53 |
| 3rd DOWN Forecast | 23.62 |
| 4th DOWN Forecast | 22.14 |
NWRN Weekly Forecast
| 4th UP Forecast | 27.94 |
| 3rd UP Forecast | 27.56 |
| 2nd UP Forecast | 27.32 |
| 1st UP Forecast | 27.09 |
| 1st DOWN Forecast | 26.41 |
| 2nd DOWN Forecast | 26.18 |
| 3rd DOWN Forecast | 25.94 |
| 4th DOWN Forecast | 25.56 |
NWRN Forecast2026
| 4th UP Forecast | 78.1 |
| 3rd UP Forecast | 61.63 |
| 2nd UP Forecast | 51.45 |
| 1st UP Forecast | 41.27 |
| 1st DOWN Forecast | 12.23 |
| 2nd DOWN Forecast | 2.05 |
| 3rd DOWN Forecast | -8.13 |
| 4th DOWN Forecast | -24.6 |
Newron Pharmaceuticals S.p.A ( SW Switzerland Symbol : NWRN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NWRN Business Profile
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its product pipeline comprises Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. Address: Via Antonio Meucci 3, Bresso, MI, Italy, 20091
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service